Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial

Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No substantive changes to the study design, eligibility criteria, endpoints, or locations were detected between the screenshots. The updates appear to be minor formatting or metadata adjustments that do not affect the page’s purpose.
    Difference
    0.4%
    Check dated 2025-11-03T13:19:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update to operating-status notice and a version bump to v3.2.0; replaces v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:14:10.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:36:59.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No other substantive content changes were detected.
    Difference
    0.2%
    Check dated 2025-09-14T09:44:46.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T07:25:34.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a range of chemical compounds related to skin and connective tissue diseases, while removing several previous topics related to breast cancer and various hormone-related agents.
    Difference
    3%
    Check dated 2025-08-31T00:47:54.000Z thumbnail image

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.